2023年2月16日

公司因持续的高性能和创新规模再次入选科睿唯安全球百强创新者榜单荷兰阿姆斯特丹-皇家飞利浦(纽约证券交易所股票代号:PHG, AEX:全球领先的医疗技术公司PHIA)在科睿唯安分析的2023年榜单中再次被评为科睿唯安全球100强创新者™，该榜单主要衡量创新[1]的一致性和规模，这得益于其在这些指标上的持续高性能。飞利浦已经连续10年被列入这一声誉良好的榜单。皇家飞利浦首席执行官Roy Jakobs表示:“我们的创新使人们能够照顾自己的健康和福祉，并帮助医生和护士提供更好、更可持续和更方便的护理。”“与众多备受尊敬的公司一起，连续第10年被评为全球百强创新者，我感到非常荣幸。在130多年来提供有意义的创新的基础上，我们将继续满怀激情地创新，我们的目标是到2030年，每年改善25亿人的生活。”飞利浦是全球领先的健康技术创新者之一，每年在研发方面投资超过17亿欧元，以实现以患者和人为中心的创新。凭借其全球布局、强大的信息学平台、动态监测和成像数据以及个人健康产品，以及支持跨环境护理的强大能力，飞利浦能够帮助改善人们的健康状况和医疗保健结果，并使医院和家庭护理更加便捷和可持续。在消费者领域，飞利浦开发创新的解决方案，支持更健康的生活方式，预防疾病，并帮助慢性疾病患者在家庭和社区中更好地生活。在诊所和医院，飞利浦与医疗保健提供商密切合作，创新和改变医疗服务的提供方式。 This includes flagship innovations such as: Ingenia Ambition MR with BlueSeal magnet , leveraging a breakthrough design where the magnetic components are completely sealed and only need seven liters of helium over its lifetime compared to roughly 1,500 liters with other systems. Additionally, it uses up to 53% less power per patient; Azurion image-guided therapy platform , supporting less invasive procedures and helping physicians deliver better patient care by combining clinical excellence with workflow automation, resulting in 17% time saving per procedure; IntelliVue patient monitoring solutions , leveraging superior hardware and predictive AI-based software and services that together monitor patients throughout their hospital stay; Sonicare 9900 Prestige , the most advanced AI-supported electric toothbrush for personalized oral care. It senses pressure, motion, tooth coverage, and other brushing actions, and then automatically adapts in real time to those consumer behaviors. The full Top 100 Global Innovators 2023 report and full list can be found here . [1] The Top 100 Global Innovators uses a complete comparative analysis of global invention data to assess the strength of every patented idea, using measures tied directly to their innovative power. To move from the individual idea strength to identify the organizations that create them more consistently and frequently, Clarivate sets two threshold criteria that potential candidates must meet and then adds a measure of their patented innovation output over the past five years. For full information on the methodology used to identify the 2023 list, see here . For further information, please contact: Ben Zwirs About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter . Attachments